Allozyne Receives New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=da419c99-6e8d-4779-95c1-f47d48cf6fb9&Preview=1 -
Date
12/23/2011 -
Company Name
Allozyne -
Mailing Address
1600 Fairview Ave E Seattle, WA 98102 -
Company Description
Allozyne, Inc., is a privately held biotechnology company focused on the development and manufacture of protein therapeutics. These technologies will enable the company to improve the efficacy of protein-based therapeutics. -
Website
http://www.allozyne.com -
Transaction Type
Venture Equity -
Transaction Amount
Undisclosed -
Transaction Round
Undisclosed -
Proceeds Purposes
Funding proceeds will be used to help the company move its multiple sclerosis drug into phase III clinical trials. -
M&A Terms
-
Venture Investor
ARCH Venture Partners -
Venture Investor
MPM Capital -
Venture Investor
OVP Venture Partners
